Fundz

Neochord reported raising $914,000 in an initial SEC Form D filing, from an offering of $2.94 Million

PRIVATEAug 29, 2024$914.3K of $2.9M raised

Amount Raised

$914,000

$914,000 sold, per SEC Form D (first sale Aug 16, 2024)

Round Type

Seed

MinneapolisManufacturingBiotechnologyHealth CareMedicalMedical Device

Quick answer

Neochord raised $914,000 in a Seed round, dated August 16, 2024. Neochord is based in Minneapolis, Minnesota, United States.

How much did Neochord raise?
Neochord raised $914,000 in a Seed round on August 16, 2024.
What does Neochord do?
NeoChord is a privately held, medical technology company and the world-leader in beating heart delivery of artificial chords in the treatment of mitral valve regurgitation.
Where is Neochord based and how big is it?
Neochord is based in Minneapolis, Minnesota, United States. Fundz records about 20 employees.
Who are the decision-makers at Neochord?
Fundz holds 1 contact at Neochord. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Neochord that raised within 45 days of this round, from Fundz verified event records.

  • Novostia raised $5.9M (Series B) on September 17, 2024.
  • PanTera raised $103M (Series A) on September 11, 2024.
  • Revolution-ZERO raised $321K (Funding Round) on August 16, 2024.
  • Aevice Health raised $7M (Seed) on August 12, 2024.
  • Xtant Medical Holdings raised $5M on August 9, 2024.
  • Bedal International raised $11M (Funding Round) on July 12, 2024.

Who to call at Neochord, and when

A new round usually means Neochord is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neochord raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neochord, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neochord. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neochord

Location

10900 73rd Avenue North, Suite 101

Minneapolis, Minnesota, United States

About

NeoChord is a privately held, medical technology company and the world-leader in beating heart delivery of artificial chords in the treatment of mitral valve regurgitation. The company is dedicated to advancing the treatment of mitral regurgitation and developing innovative therapies for degenerative mitral valve disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neochord raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts55 people are listed at Neochord. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Neochord's next move

See what Strategic adds

Neochord raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.